Completed PHASE1 INTERVENTIONAL 5-arm NCT02165098

Cariprazine: Comparison of Slow- and Immediate-release Forms

A Single-Dose Study to Evaluate the Pharmacokinetic, Safety, Tolerability Profile and the Effects of Food on the Pharmacokinetics of Different Formulations of Cariprazine in Healthy Male Subjects

Sponsor: Gedeon Richter Plc.

Conditions Pharmacokinetic Profile

Interventions Cariprazine PR tablet A Cariprazine PR tablet B Cariprazine capsule Cariprazine prolonged release tablet A Cariprazine prolonged release tablet B

Updated 6 times since 2017 Last updated: Mar 23, 2016 Started: Jun 30, 2014 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Pharmacokinetic Profile, this trial is completed. The trial is conducted by Gedeon Richter Plc. and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gedeon Richter Plc.

Data source: Gedeon Richter Plc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom